COMMUNIQUÉS West-GlobeNewswire

Correction: ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
20/10/2026
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led [...]
Thought Leadership & Innovation Foundation Appoints Dr. Neena Haider to Board of Directors
20/10/2026
Renowned geneticist, precision medicine innovator and founder of Shifa Precision joins TLI leadership to advance science-driven solutions that improve health outcomes MCLEAN, Va., Oct. 20, 2026 (GLOBE NEWSWIRE) -- The [...]
EssilorLuxottica: Chiffre d'affaires T3 - Chiffre d’affaires en croissance de +9,0 % au T3, +7,2 % à taux de change constants
20/10/2026
Chiffre d’affaires en croissance de +9,0 % au T3, +7,2 % à taux de change constants Chiffre d’affaires du Groupe en hausse de +9,0 %, à 7 486 millions d’euros au T3, +7,2 % à taux de change constants¹, après une [...]
EssilorLuxottica: Q3 2026 Revenue - Revenue growth at 9.0% in Q3, +7.2% at constant currency
20/10/2026
Revenue growth at 9.0% in Q3, +7.2% at constant currency Group revenue +9.0% to Euro 7,486 million in Q3, +7.2% at constant ER 1 on top of double-digit growth of last year Group revenue +6.8% to Euro 22,304 million in [...]
La télésurveillance cardiaque au KFSH réduit de 46 % les hospitalisations liées à l’insuffisance cardiaque
20/10/2026
RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a réduit de 46,4 % les hospitalisations pour insuffisance cardiaque décompensée chez les patients [...]
Le KFSH réduit de 75 % le temps d’attente aux urgences grâce à un système de gestion du flux de patients basés sur l’IA
20/10/2026
RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a réduit de 75 % la durée d’attente médiane aux urgences de son établissement de Riyad, passant de [...]
Le KFSH inaugure une unité de cathétérisme cardiaque directement au sein des urgences afin d’accélérer la prise en charge des cas critiques
20/10/2026
RIYAD, Arabie saoudite, 20 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) a mis en place un laboratoire de cathétérisme cardiaque au sein du service des urgences de son [...]
Inside information: Orion upgrades full-year outlook for 2026
20/10/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 20 OCTOBER 2026 at 20.20 EEST Inside information: Orion upgrades full-year outlook for 2026 Orion Corporation upgrades the full-year outlook for 2026 both [...]
Alignment Health Plan Recognized Among U.S. News & World Report’s 2027 Best Insurance Companies for Medicare Advantage
20/10/2026
Alignment earns “Best” rating in Arizona, California, Nevada, North Carolina and Texas for the second consecutive year, reflecting strong performance in care quality, prevention and satisfaction ORANGE, Calif., Oct. 20 [...]
Biomolecular Holdings Announces Issuance of Foundational Patent for Revolutionary Dimeric Fusion Protein Technology
20/10/2026
BURLINGAME, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Biomolecular Holdings LLC, a privately held biotechnology company advancing next-generation antibody architectures, today announced that the United States Patent and [...]
BioVie Presents Data on Bezisterim in Parkinson’s Disease at the 2026 American Neurological Association Annual Meeting
20/10/2026
Parkinson’s patients elevated baseline inflammation demonstrated statistically significant improvements in both motor and non-motor symptoms with Bezisterim compared to placebo. CARSON CITY, Nev., Oct. 20, 2026 (GLOBE [...]
Solid Biosciences to Present Research Across Gene Therapy Development, Delivery and Manufacturing at ESGCT 2026
20/10/2026
CHARLESTOWN, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
InnovAge to Announce Fiscal First Quarter 2027 Financial Results and Host Conference Call Tuesday, November 3, 2026
20/10/2026
DENVER, Oct. 20, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible [...]
Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast
20/10/2026
Investor webcast at 4:30 p.m. ET on October 22 to discuss ORIGIN 3 final efficacy results for TRUTAKNA ™ (atacicept-vymj) featured in a late-breaking oral presentation during the opening plenary session of ASN Kidney [...]
Revolution Medicines Begins Treating Patients in Phase 3 RASolve 308 Trial Evaluating Zoldonrasib in Combination with Pembrolizumab and Chemotherapy as First-Line Treatment for Patients with Metastatic RAS G12D Non-Squamous Non-Small Cell Lung Cancer
20/10/2026
REDWOOD CITY, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for [...]
PDS Biotechnology Appoints Three Accomplished Pharma Industry Executives to Board of Directors
20/10/2026
John Dawson CBE, Deborah Ramsdell and Bruce Wendel bring corporate development, commercialization, and regulatory experience to the Company as it advances PDS0301 toward Phase 3 trial in Metastatic Colorectal Cancer ( [...]
YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs
20/10/2026
TAIPEI, Taiwan, and BOTHELL, Wash., Oct. 20, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection and [...]
Route 92 Medical Announces $100 Million Corporate Debt Facility
20/10/2026
Financing Strengthens Balance Sheet and Supports Continued Product Innovation and Commercial Growth WEST JORDAN, Utah, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a medical technology company dedicated to [...]
Palisade Bio Presents Rapid Endoscopic Improvement and New Translational Evidence for PALI-2108 in Inflammatory Bowel Disease at UEG Week 2026
20/10/2026
Five-patient Phase 1b Crohn’s disease cohort showed a 47.5% reduction in mean endoscopic disease activity and a 58.8% reduction in mean fecal calprotectin after 14 days Intestinal exposure and tissue analyses strengthen [...]

Pages